LB
16
9
DOV
48
2
CAH
44
7
JPM
59
6
SCHW
40
3
CCI
30
2
QRVO
16
-6
PCG
59
9
HES
49
2
CSCO
63
5
JNPR
59
3
ZION
49
9
BAX
38
2
HPE
48
2
NSC
33
6
EOG
28
2
CRM
65
6
EXPE
83
8
EMR
57
7
SHW
42
5
LB
16
9
DOV
48
2
CAH
44
7
JPM
59
6
SCHW
40
3
CCI
30
2
QRVO
16
-6
PCG
59
9
HES
49
2
CSCO
63
5
JNPR
59
3
ZION
49
9
BAX
38
2
HPE
48
2
NSC
33
6
EOG
28
2
CRM
65
6
EXPE
83
8
EMR
57
7
SHW
42
5
Financhill
Back

Intellia Therapeutics Vs. BridgeBio Pharma Industry Stock Comparison

Sell
5

NTLA
Intellia Therapeutics

Last Price:
$12.20
Seasonality Move:
-3.92%
Sell
39

BBIO
BridgeBio Pharma

Last Price:
$26.49
Seasonality Move:
-20.12%
Sell
5
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $12.21. The Score for NTLA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma a Buy, Sell or Hold?

  • The current BridgeBio Pharma [BBIO] share price is $26.50. The Score for BBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $12.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight buying pressure.

BBIO Stock Price Chart

What is BridgeBio Pharma's stock price today?

  • The BridgeBio Pharma share price today is $26.50
    The current trend is moderately bearish and BBIO is experiencing slight buying pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 34.7 Sell
Chaikin Money Flow: 734391 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13 - 14.98) Sell
Bollinger Bands (100): (14.92 - 22.24) Sell

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 49.08 Sell
Chaikin Money Flow: 316290 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.3 - 28.44) Buy
Bollinger Bands (100): (24.03 - 27.65) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.92 Sell
20-day SMA: 14.03 Sell
50-day SMA: 15.6 Sell
200-day SMA: 21.65 Sell
8-day EMA: 12.86 Sell
20-day EMA: 13.76 Sell
50-day EMA: 15.52 Sell
200-day EMA: 21.32 Sell

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.3 Sell
20-day SMA: 27.21 Sell
50-day SMA: 25.73 Buy
200-day SMA: 26.64 Sell
8-day EMA: 27.01 Sell
20-day EMA: 26.87 Sell
50-day EMA: 26.24 Buy
200-day EMA: 26.64 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.19 per share.

BridgeBio Pharma Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $1.07 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BridgeBio Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):